Frank Schmidtmann

Frank Schmidtmann is currently the Head of Care Solutions at Evonik Korea, where they leverage their extensive background in chemistry and technology. They earned a B.S. in Chemistry with a concentration in Biochemistry from St. John Fisher University and completed a Doctorate in Chemistry at the University of Virginia. Previously, Frank held various positions at Evonik, including Technology Manager and Research and Development Group Leader, along with leadership roles in pharmaceutical research at Dogwood Pharmaceuticals and Pinnacle Pharmaceuticals. Their postdoctoral work involved the synthesis of bleomycin analogs, showcasing their expertise in chemical synthesis throughout their career.